# Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings

> **Open Intelligence Dossier** · First detected: 2026-08-24 22:07 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings" is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include BioSpace and BioPharma Dive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| BioSpace | REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQR0U5YjhlOU5hRExHNWJyczIxNXBDd21JMmQzZDZfalVzVU44UkMwN21yc3A1UXRiX0lpbkpfMkZZNjl4M1YzeTdnVlJ2VDY2U0w2YWVrZWtMb0x2VWpvaGVuSTZuYzlQcDI2VjhHNVgzUVZKeWdHYk9zX0JMZVY3RUdULWVqdzZlNjREWjBtY2gtV1B4b09HUm11V29CUlZWaldidlA0Nld4NWo2Ty00ODZjNA?oc=5) |
| BioPharma Dive | Safety concerns spur FDA to again halt testing of Regenxbio gene therapy | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxOSmZGZ0Y1Ym41MWNEeURwekxkVlJxSTJEc1o1WHRzUFRxQXNwV2s1VlV3YU1hYlhQSTRMRFJIVU0xYUZGbXpFUTNBSXpoeWlNY2lSSk5VdkV4Zkw5aHJBTkMzTUliQVpQcGU1eHhDcTBpMkpwZ2pjS3A0QnNEUmpXZDJOT0VBUVk1eFVPRkxpZjNDUQ?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-24/regenxbio-gene-therapy-refiling-plan-derailed-by-fda-hold-over-spine-mri*